Reactive granulomatous dermatitis arising in the setting of interleukin-17 inhibition successfully treated with tofacitinib.
Saved in:
| Title: | Reactive granulomatous dermatitis arising in the setting of interleukin-17 inhibition successfully treated with tofacitinib. |
|---|---|
| Authors: | Spaulding SL; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Wride AM; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Murphy MJ; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Junejo MH; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Damsky W; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. |
| Source: | JAAD case reports [JAAD Case Rep] 2025 Oct 14; Vol. 69, pp. 194-197. Date of Electronic Publication: 2025 Oct 14 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101665210 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5126 (Print) Linking ISSN: 23525126 NLM ISO Abbreviation: JAAD Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
